Optimi Health Seek Regulatory Nod for Initial Testing of Psychedelic Drug Combination
Optimi Health Seek Regulatory Nod for Initial Testing of Psychedelic Drug Combination
Optimi Health 为迷幻药物组合的初步测试寻求监管部门的点头
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册